Abstract
Background
The aim of this study was to investigate the clinical characteristics and outcomes of elderly patients (≥70 years old) undergoing curative hepatectomy for hepatocellular carcinoma (HCC).
Methods
Clinicopathological data and treatment outcomes in 100 elderly patients (≥70 years old) and 120 control patients (≤70 years old) with HCC who underwent curative hepatectomy between 2000 and 2011 were retrospectively collected and compared.
Results
The overall survival rate was similar between the two groups, but the disease-free survival rate was worse in the elderly group when compared with the control group. Prognostic factors for overall and disease-free survival were the same when comparing the two groups. The elderly group had higher rate of females (p = 0.0230), higher hepatitis C virus infection rate (p = 0.0090), higher postoperative pulmonary complication rate (p = 0.0484), lower rate of response to interferon (IFN) therapy (p = 0.0203) and shorter surgical time (p = 0.0337) when compared with the control group. The overall recurrence rate was higher in the elderly group than in the control group (p = 0.0346), but the rate of recurrence within 2 years after the operation was similar when comparing the two groups.
Conclusion
The survival of elderly patients with HCC was similar to that of younger patients. However, the disease-free survival was worse in elderly patients than in younger patients. Aggressive antiviral therapy (e.g. IFN therapy) may be necessary to improve the disease-free survival, even in elderly patients. Additionally, clinicians should be aware of the risk of pulmonary complications in elderly patients after hepatectomy.
Similar content being viewed by others
Abbreviations
- AFP:
-
alpha-fetoprotein
- ASA:
-
American Society of Anaesthesiologists
- AST:
-
Aspartate aminotransferase
- ALT:
-
Alanine aminotransferase
- BMI:
-
Body mass index
- CT:
-
Computed tomography
- HA:
-
Hyaluronic acid
- HCC:
-
Hepatocellular carcinoma
- ICG:
-
Indocyanine green clearance
- IFN:
-
Interferon
- L3-AFP:
-
Lens culinaris agglutinin-reactive fraction of AFP
- MRI:
-
Magnetic resonance imaging
- MVI:
-
Microvascular invasion
- PIVKA-II:
-
Protein-induced vitamin K absence-II
- PT-INR:
-
Prothrombin time-international normal ratio
- SM:
-
Surgical margin
- TACE:
-
Transcatheter arterial chemoembolisation
- TB:
-
Total bilirubin
- US:
-
Ultrasonography
References
Dohmen K, Shigematsu H, Irie K, Ishibashi H. Trends in clinical characteristics, treatment and prognosis of hepatocellular carcinoma. Hepatogastroenterology 2003; 50: 1872–1877.
Ikai I, Arii S, Okazaki M et al. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res 2007; 37: 676–691.
Umemura T, Kiyosawa K. Epidemiology of hepatocellular carcinoma in Japan. Hepatol Res 2007; 37 Suppl 2: S95-S100.
Lui WY, Chau GY, Wu CW, King KL. Surgical resection of hepatocellular carcinoma in elderly cirrhotic patients. Hepatogastroenterology 1999; 46: 640–645.
Nagasue N, Chang YC, Takemoto Y et al. Liver resection in the aged (seventy years or older) with hepatocellular carcinoma. Surgery 1993; 113: 148–154.
Yamamoto K, Takenaka K, Matsumata T et al. Right hepatic lobectomy in elderly patients with hepatocellular carcinoma. Hepatogastroenterology 1997; 44: 514–518.
Yanaga K, Kanematsu T, Takenaka K et al. Hepatic resection for hepatocellular carcinoma in elderly patients. Am J Surg 1988; 155: 238–241.
Zhou XP, Quan ZW, Cong WM et al. Micrometastasis in surrounding liver and the minimal length of resection margin of primary liver cancer. World J Gastroenterol 2007; 13: 4498–4503.
Poon RT, Fan ST, Lo CM et al. Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol 1999; 94: 2460–2466.
Wynne HA, Cope LH, Mutch E et al. The effect of age upon liver volume and apparent liver blood flow in healthy man. Hepatology 1989; 9: 297–301.
Marchesini G, Bua V, Brunori A et al. Galactose elimination capacity and liver volume in aging man. Hepatology 1988; 8: 1079–1083.
Zoli M, Magalotti D, Bianchi G et al. Total and functional hepatic blood flow decrease in parallel with ageing. Age Ageing 1999; 28: 29–33.
Sato T. Minophagen Med Rev. Karei to shoukaki 2001; 46: 265–277.
Zoli M, Iervese T, Abbati S et al. Portal blood velocity and flow in aging man. Gerontology 1989; 35: 61–65.
Hirokawa F, Hayashi M, Miyamoto Y et al. A novel method using the VIO soft-coagulation system for liver resection. Surgery 2011; 149: 438–444.
Huang J, Li BK, Chen GH et al. Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy. J Gastrointest Surg 2009; 13: 1627–1635.
Wan J, Grossman HB. Bladder carcinoma in patients age 40 years or younger. Cancer 1989; 64: 178–181.
Shaha AR, Shah JP, Loree TR. Risk group stratification and prognostic factors in papillary carcinoma of thyroid. Ann Surg Oncol 1996; 3: 534–538.
Leff DR, Chen A, Roberts D et al. Colorectal cancer in the young patient. Am Surg 2007; 73: 42–47.
Katai H, Sasako M, Sano T, Maruyama K. Gastric carcinoma in young adults. Jpn J Clin Oncol 1996; 26: 139–143.
Cho SJ, Yoon JH, Hwang SS, Lee HS. Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients? J Gastroenterol Hepatol 2007; 22: 1226–1231.
Chen CH, Chang TT, Cheng KS et al. Do young hepatocellular carcinoma patients have worse prognosis? The paradox of age as a prognostic factor in the survival of hepatocellular carcinoma patients. Liver Int 2006; 26: 766–773.
Ng IO, Ng MM, Lai EC, Fan ST. Pathologic features and patient survival in hepatocellular carcinoma in relation to age. J Surg Oncol 1996; 61: 134–137.
Lam CM, Chan AO, Ho P et al. Different presentation of hepatitis B-related hepatocellular carcinoma in a cohort of 1863 young and old patients - implications for screening. Aliment Pharmacol Ther 2004; 19: 771–777.
Aramaki M, Kawano K, Sasaki A et al. Hepatocellular carcinoma in young adults. Hepatogastroenterology 2005; 52: 1795–1797.
Yamazaki Y, Kakizaki S, Sohara N et al. Hepatocellular carcinoma in young adults: the clinical characteristics, prognosis, and findings of a patient survival analysis. Dig Dis Sci 2007; 52: 1103–1107.
Chang PE, Ong WC, Lui HF, Tan CK. Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome. J Gastroenterol 2008; 43: 881–888.
Kaibori M, Matsui K, Ishizaki M et al. Hepatic resection for hepatocellular carcinoma in the elderly. J Surg Oncol 2009; 99: 154–160.
Lee CR, Lim JH, Kim SH et al. A comparative analysis of hepatocellular carcinoma after hepatic resection in young versus elderly patients. J Gastrointest Surg 2012; 16: 1736–1743.
Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005; 5: 558–567.
Mazzaferro V, Romito R, Schiavo M et al. Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis. Hepatology 2006; 44: 1543–1554.
Nishiguchi S, Tamori A, Kubo S. Effect of long-term postoperative interferon therapy on intrahepatic recurrence and survival rate after resection of hepatitis C virus-related hepatocellular carcinoma. Intervirology 2005; 48: 71–75.
Kubo S, Nishiguchi S, Hirohashi K et al. Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomised, controlled trial. Ann Intern Med 2001; 134: 963–967.
Shen YC, Hsu C, Chen LT et al. Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): a meta-regression approach. J Hepatol 2010; 52: 889–894.
Uenishi T, Kubo S, Hirohashi K et al. Relationship between response to previous interferon therapy and postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma. Hepatol Res 2002; 24: 404–412.
Uenishi T, Nishiguchi S, Tanaka S et al. Response to interferon therapy affects risk factors for postoperative recurrence of hepatitis C virus-related hepatocellular carcinoma. J Surg Oncol 2008; 98: 358–362.
Saneto H, Kobayashi M, Kawamura Y et al. Clinicopathological features, background liver disease, and survival analysis of HCV-positive patients with hepatocellular carcinoma: differences between young and elderly patients. J Gastroenterol 2008; 43: 975–981.
Su CW, Lei HJ, Chau GY et al. The effect of age on the long-term prognosis of patients with hepatocellular carcinoma after resection surgery: a propensity score matching analysis. Arch Surg 2012; 147: 137–144.
Fortner JG, Lincer RM. Hepatic resection in the elderly. Ann Surg 1990; 211: 141–145.
Zilberberg MD, Epstein SK. Acute lung injury in the medical ICU: comorbid conditions, age, aetiology, and hospital outcome. Am J Respir Crit Care Med 1998; 157: 1159–1164.
Fuso L, Cisternino L, Di Napoli A et al. Role of spirometric and arterial gas data in predicting pulmonary complications after abdominal surgery. Respir Med 2000; 94: 1171–1176.
Smith PR, Baig MA, Brito V et al. Postoperative pulmonary complications after laparotomy. Respiration 2010; 80: 269–274.
Jiang L, Yang KH, Guan QL et al. Laparoscopy-assisted gastrectomy versus open gastrectomy for resectable gastric cancer: an update meta-analysis based on randomized controlled trials. Surg Endosc 2013.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hirokawa, F., Hayashi, M., Miyamoto, Y. et al. Surgical Outcomes and Clinical Characteristics of Elderly Patients Undergoing Curative Hepatectomy for Hepatocellular Carcinoma. J Gastrointest Surg 17, 1929–1937 (2013). https://doi.org/10.1007/s11605-013-2324-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-013-2324-0